
For cancer, a biopharmaceutical company and UC San Diego test another kind of immune cell
by Bradley J. Fikes, The San Diego Union-TribuneWhen the U.S. Food and Drug Administration approved the first cell-based gene therapies for cancer in 2017, advanced malignancies once seen as terminal
Updated on: December 18,2023
23

For cancer, a biopharmaceutical company and UC San Diego test another kind of immune cell
by Bradley J. Fikes, The San Diego Union-TribuneWhen the U.S. Food and Drug Administration approved the first cell-based gene therapies for cancer in 2017, advanced malignancies once seen as terminal
Updated on:December 18,2023
23
